Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Aspera Biomedicines launched its second ADAR1p150 crystallization to the ISS aboard SpaceX CRS-34

stem cells drive relapse in many cancers by overexpressing a stress-response protein called ADAR1, which edits RNA to help tumors hide from the immune system and regenerate after treatment. Aspera’s lead therapeutic, Rebecsinib, acts as a “kill...

Peter Menziuso named EVP and President of BD Interventional

annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more...

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

had been reported. “These new data add to the growing body of real-world evidence generated in urology practices and help inform how re-induction with ADSTILADRIN is being evaluated outside of the controlled clinical trial setting, particularly in...

Biohack skin longevity with Futurecode Booster

it. Now, that same mindset is reshaping how we view skin care: with the right inputs and targeted support, we can help optimize our skin's natural systems for repair, strength, and performance. Dermalogica's new FutureCode Booster brings biohacking...

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

Smart, Senior Vice President, Mission, Susan G. Komen, said: “Providing patients with early breast cancer more options to help prevent progression to metastatic disease can lead to improved outcomes. Progression and recurrence remain among the most...

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

protocols, pupillometry is increasingly being recognized as a way to eliminate subjectivity, improve documentation, and help clinicians identify meaningful changes in pupillary response over time. Recent guidelines from the American College of...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

SIRT1, a member of the sirtuin family, plays an important role in cellular protection and repair. Together, these pathways help protect cells against oxidative stress, inflammation, toxins, and environmental stressors, while also supporting...

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

said David Fairchild, MD, Chief Medical Officer, Retail Health, CVS Health. "By meeting patients where they are, we can help address risk factors earlier which ultimately supports long-term health outcomes and overall health care expenditures."...

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

manufacturing. Kerri brings a strong track record of partnership, operational excellence, and program execution that will help us continue delivering for the clients and patients we serve." McCullough Wood's appointment comes as Avid continues to...

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

behind the BEAR Implant,” Rushdy said. “The opportunity now is to expand use and advance new indications, with the goal of helping people with ACL tears return to an active lifestyle while preserving long-term knee health. I’m excited to work with...

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

Co-Founder and CEO of Avenacy. “This presentation enables healthcare providers to deliver safe and efficient care while helping reduce preparation time and potential medication errors, reinforcing our long-standing value proposition as a trusted...

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

clinical trial found that prenatal multivitamins containing 5-methyltetrahydrofolate (5-MTHF) instead of folic acid may help minimize levels of unmetabolized folic acid (UMFA) in pregnant individuals while maintaining adequate folate status in both...

Viralgen Teams with Elaaj Bio to Advance CDKL5 Deficiency Gene Therapy

with Elaaj Bio and the Loulou Foundation, we're uniting complementary strengths in development and manufacturing to help accelerate ELJ-101 toward clinical development." CDKL5 Deficiency Disorder (CDD) is a rare and severe developmental and...

Amazon Pharmacy Expands Same-Day Delivery and Kiosk Access for New Ozempic® Pill

expanded selection and reliable, convenient access to the latest treatments like the Ozempic pill for type 2 diabetes, helping reduce the friction that comes with accessing breakthrough medications," said Tanvi Patel, Vice President and General...

Study Finds Testosterone Therapy Boosts Women’s Energy, Mood, and Quality of Life

DO, Medical Director at Joi + Blokes. “This isn’t just about libido. It’s about restoring energy, improving mood, and helping women feel like themselves again.” In addition to symptom improvements, participants demonstrated favorable changes in key...

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

of Cincinnati College of Medicine to advance clinical research on infant gut health and breast milk composition, helping inform the company's long-term roadmap, including future research and personalized testing solutions. NurtureBio's approach is...

Elizabeth Nanouris Named VP of Business Operations at InFocus Clinical Research

for long-term success. Elizabeth has also supported global Phase 3 programs, built scalable proposal frameworks and helped advance partnerships moving early-stage science into clinical development. "The best clinical organizations aren't built on...

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

same efficacy and safety profile as the original formulation offered in a smaller pill.1-3 The product has been renamed to help patients and healthcare professionals more easily recognize the available treatment options for type 2 diabetes that...

Incyte announces FDA approval of Jakafi XR for treating myelofibrosis, polycythemia vera, and graft-versus-host disease

Cancer Medicine at The University of Texas MD Anderson Cancer Center. “Since its initial approval in 2011, ruxolitinib has helped transform the treatment landscape for patients with MPNs and GVHD. With the approval of Jakafi XR, appropriate...

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

including development, launch, and commercialization, will enable the continuation of our clinical programs and help deliver on the potential for our pipeline.” Under the terms of the agreement, UCB will pay US $2 billion upfront payments and up to...